• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

面部恶性雀斑样痣与色素性日光性角化病及日光性雀斑的皮肤镜鉴别

Dermoscopic Differentiation of Facial Lentigo Maligna from Pigmented Actinic Keratosis and Solar Lentigines.

作者信息

Ozbagcivan Ozlem, Akarsu Sevgi, Ikiz Necla, Semiz Fatma, Fetil Emel

机构信息

Ozlem Ozbagcivan, MD, Dokuz Eylul University, Faculty of Medicine, Department of Dermatology, 35340 Inciralti, Izmir, Turkey;

出版信息

Acta Dermatovenerol Croat. 2019 Sep;27(3):146-152.

PMID:31542057
Abstract

The differential diagnosis of lentigo maligna (LM) from pigmented actinic keratosis (PAK) and solar lentigines (SL) remains a challenge for clinicians, especially in the early stages of LM when there are no distinctive dermoscopic features. Objective of this study was to evaluate the frequencies of selective dermoscopic criteria in LM, PAK, and SL and to find the specific combination of distinguishing dermoscopic criteria for LM. Dermoscopists blinded to histopathological diagnosis evaluated 42 LM, 107 PAK, and 16 SL for the presence of predefined dermoscopic criteria. The differences in the presence of dermoscopic criteria between LM and others were evaluated with the chi-squared test or Fisher's exact test as appropriate. Multivariate logistic regression analysis with the forward conditional stepwise method were performed and odds ratios and corresponding 95% confidence intervals for LM, PAK, and SL were calculated. LM, PAK, and SL showed many common dermoscopic findings. In multivariate logistic regression analysis, darkening at dermoscopic examination (sevenfold), gray circles (sevenfold), target-like pattern (sixfold), gray rhomboids (sixfold), and slate-gray dots/globules (threefold) represented the strongest predictors of LM, while hyperkeratosis (thirteenfold), white circles (twelvefold), and red rhomboids (sixfold) represented the strongest predictors of PAK. The dermoscopic diagnosis of a given lesion should be based on the presence of the combination of specific dermoscopic criteria rather than a single benign or malignant criterion. Our results suggest that the presence of darkening at dermoscopic examination, gray circles, target-like pattern, gray rhomboids, and slate-gray dots/globules should be considered supportive findings for the diagnosis of early LM.

摘要

对临床医生而言,鉴别恶性雀斑样痣(LM)与色素性光化性角化病(PAK)及日光性雀斑(SL)仍是一项挑战,尤其是在LM早期,此时尚无明显的皮肤镜特征。本研究的目的是评估LM、PAK和SL中选择性皮肤镜标准的出现频率,并找出区分LM的皮肤镜标准的特定组合。对组织病理学诊断不知情的皮肤镜检查人员评估了42例LM、107例PAK和16例SL是否存在预先定义的皮肤镜标准。根据情况,采用卡方检验或Fisher精确检验评估LM与其他疾病在皮肤镜标准出现情况上的差异。采用向前条件逐步法进行多因素逻辑回归分析,并计算LM、PAK和SL的比值比及相应的95%置信区间。LM、PAK和SL显示出许多共同的皮肤镜表现。在多因素逻辑回归分析中,皮肤镜检查时颜色加深(七倍)、灰色圆圈(七倍)、靶样模式(六倍)、灰色菱形(六倍)和蓝灰色点/小球(三倍)是LM最强的预测指标,而角化过度(十三倍)、白色圆圈(十二倍)和红色菱形(六倍)是PAK最强的预测指标。对特定病变的皮肤镜诊断应基于特定皮肤镜标准的组合,而非单一的良性或恶性标准。我们的结果表明,皮肤镜检查时颜色加深、灰色圆圈、靶样模式、灰色菱形和蓝灰色点/小球的出现应被视为早期LM诊断的支持性表现。

相似文献

1
Dermoscopic Differentiation of Facial Lentigo Maligna from Pigmented Actinic Keratosis and Solar Lentigines.面部恶性雀斑样痣与色素性日光性角化病及日光性雀斑的皮肤镜鉴别
Acta Dermatovenerol Croat. 2019 Sep;27(3):146-152.
2
Inner gray halo, a novel dermoscopic feature for the diagnosis of pigmented actinic keratosis: clues for the differential diagnosis with lentigo maligna.内灰色晕环,一种用于诊断色素性光化性角化病的新型皮肤镜特征:与恶性雀斑样痣鉴别诊断的线索。
J Am Acad Dermatol. 2014 Oct;71(4):708-15. doi: 10.1016/j.jaad.2014.05.025. Epub 2014 Jun 17.
3
Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis.面部恶性雀斑样痣与色素性光化性角化病的皮肤镜线索鉴别。
Br J Dermatol. 2016 May;174(5):1079-85. doi: 10.1111/bjd.14355. Epub 2016 Jan 20.
4
A comparison of dermoscopic features among lentigo senilis/initial seborrheic keratosis, seborrheic keratosis, lentigo maligna and lentigo maligna melanoma on the face.面部脂溢性角化病/早期脂溢性角化病、脂溢性角化病、恶性雀斑样痣及恶性雀斑样痣黑色素瘤的皮肤镜特征比较
J Dermatol. 2004 Nov;31(11):884-9. doi: 10.1111/j.1346-8138.2004.tb00621.x.
5
A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis.一种用于鉴别诊断面部恶性雀斑样痣和色素性光化性角化病的新型皮肤镜算法。
Eur J Dermatol. 2018 Apr 1;28(2):162-168. doi: 10.1684/ejd.2018.3246.
6
Diagnosis and management of facial pigmented macules.面部色素斑的诊断与处理。
Clin Dermatol. 2014 Jan-Feb;32(1):94-100. doi: 10.1016/j.clindermatol.2013.05.030.
7
Dermoscopy of Pigmented Actinic Keratosis of the Face: A Study of 232 Cases.面部色素性光化性角化病的皮肤镜检查:232例研究
Actas Dermosifiliogr. 2017 Nov;108(9):844-851. doi: 10.1016/j.ad.2017.05.002. Epub 2017 Jul 11.
8
Key points in dermoscopic differentiation between lentigo maligna and solar lentigo.痣样良性黑素细胞瘤和老年性黑子在皮肤镜下鉴别要点。
J Dermatol. 2011 Jan;38(1):53-8. doi: 10.1111/j.1346-8138.2010.01132.x.
9
The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis.皮肤镜下反推法显著提高了人眼阅读者对恶性雀斑样痣诊断的准确性。
J Am Acad Dermatol. 2021 Feb;84(2):381-389. doi: 10.1016/j.jaad.2020.06.085. Epub 2020 Jun 24.
10
Lentigo Maligna: Keys to Dermoscopic Diagnosis.恶性雀斑样痣:皮肤镜诊断要点
Actas Dermosifiliogr. 2016 Jul-Aug;107(6):489-97. doi: 10.1016/j.ad.2016.01.001. Epub 2016 Feb 11.

引用本文的文献

1
Zoom-in Dermoscopy for Facial Tumors.面部肿瘤的放大皮肤镜检查
Diagnostics (Basel). 2025 Jan 30;15(3):324. doi: 10.3390/diagnostics15030324.
2
Incomplete Excision Rate for Lentigo Maligna and Associated Risk Factors.恶性雀斑样痣的不完全切除率及相关危险因素。
Acta Derm Venereol. 2024 Oct 3;104:adv40535. doi: 10.2340/actadv.v104.40535.
3
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis.光动力疗法是治疗面部色素性光化性角化病的有效方法。
Dermatol Ther (Heidelb). 2023 Jun;13(6):1265-1276. doi: 10.1007/s13555-023-00924-0. Epub 2023 May 10.
4
Reactive Pigmentation of Skin Graft Mimicking a Lentigo Maligna Recurrence: a Case Report.皮肤移植的反应性色素沉着酷似恶性雀斑样痣复发:一例报告
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022054. doi: 10.5826/dpc.1202a54. eCollection 2022 May.